How many studies have been conducted on Tiagabine?

BiohacksAI has indexed 298 PubMed studies on Tiagabine, including 38 randomized controlled trials (RCTs). 50% of studies involve human subjects.

What are the main research areas for Tiagabine?

The primary research domains for Tiagabine are 🧘 Stress & Anxiety, 😴 Sleep, 🧠 Memory. This is based on analysis of 298 PubMed studies using the BiohacksAI evidence platform.

Tiagabine

A nipecotic acid derivative that acts as a GABA uptake inhibitor and anticonvulsant agent. It is used in the treatment of EPILEPSY, for refractory PARTIAL SEIZURES.

298+ PubMed studies analyzed · 38 RCTs · Evidence Score: 50.4

Research Domains

Tiagabine has been studied across 13 research domains including 🧘 Stress & Anxiety, 😴 Sleep, 🧠 Memory, 🧠 Cognitive, 🌤️ Mood & Depression. The primary research focus is 🧘 Stress & Anxiety with 49% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tiagabine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Loading evidence profile...

This evidence profile for Tiagabine is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.